[Federal Register Volume 62, Number 64 (Thursday, April 3, 1997)]
[Notices]
[Page 15897]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-8479]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Institute for 
Occupational Safety and Health: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Board of Scientific Counselors, National Institute for 
Occupational Safety and Health (BSC, NIOSH).
    Time and Date: 9 a.m.-5:15 p.m., April 30, 1997.
    Place: Sheraton Washington Hotel, Warren Room, 2660 Woodley 
Road, NW, Washington, DC 20008.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 50 people.
    Purpose: The BSC, NIOSH is charged with providing advice to the 
Director, NIOSH on NIOSH research programs. Specifically, the Board 
shall provide guidance on the Institute's research activities 
related to developing and evaluating hypotheses, systematically 
documenting findings, and disseminating results.
    Matters To Be Discussed: Agenda items include a report from the 
Director of NIOSH, Interagency Relationships, National Occupational 
Research Agenda, Exposure Control vs. Exposure Prevention, NIOSH 
Health Communications Program, Child Labor Update, NIOSH/NCI Diesel 
Study, and future activities of the Board.
    The Board will consider further the NIOSH/National Cancer 
Institute (NCI) study entitled ``A Cohort Mortality Study with a 
Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among 
Non-Metal Miners'' (``diesel study''). At its January 14, 1997, 
meeting, the Board and members of the public provided comments to 
NIOSH and NCI on the August 1995 draft protocol for the diesel 
study. As provided for in the Federal Register notice announcing the 
meeting (61 FR 66052), the agencies also accepted written comments 
on the diesel study. NIOSH and NCI have reviewed all comments 
received, both written and oral, and prepared a summarization of 
those comments with responses to each. At this April 30, 1997, 
meeting the Board will consider the proposed Agency responses to 
comments and their impact on the study protocol. Following this 
April 30, 1997, meeting, the agency will prepare a revised diesel 
study protocol which then will be reviewed by the Board at a future 
meeting to be announced. At the April 30, 1997, meeting members of 
the public will have the opportunity to make limited oral 
statements, time permitting. Persons who wish to make oral 
statements should make a written request to Bryan D. Hardin, Ph.D., 
Executive Secretary, NIOSH, Room 715-H, Hubert H. Humphrey Building, 
200 Constitution Avenue, SW, Washington, DC 20201, telephone 202/
205-8556, FAX 202/260-4464, Internet address: <a href="/cdn-cgi/l/email-protection#a7c5c3cf96e7c4c3c489c0c8d1"><span class="__cf_email__" data-cfemail="1173757920517275723f767e67">[email protected]</span></a>.
    Copies of the agencies' summary of comments on the diesel study 
protocol may be obtained from Michael Attfield, Ph.D., NIOSH Project 
Director, Division of Respiratory Disease Studies, NIOSH, Mailstop 
234, 1095 Willowdale Road, Morgantown, West Virginia 26505-2888, 
telephone 304/285-5751, Internet address: <a href="/cdn-cgi/l/email-protection#204d444111604344430e474f56"><span class="__cf_email__" data-cfemail="7518111444351611165b121a03">[email protected]</span></a>.
    Agenda items are subject to change as priorities dictate.
    For More Information Contact: Bryan D. Hardin, Ph.D., Executive 
Secretary, BSC, NIOSH, CDC, 200 Independence Avenue, SW, Humphrey 
Building, Washington, DC 20201, telephone 202/205-8556.

    Dated: March 28, 1997.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 97-8479 Filed 4-2-97; 8:45 am]
BILLING CODE 4163-19-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>